Your browser doesn't support javascript.
loading
Brief Report: Clinical Response, Toxicity, and Resistance Mechanisms to Osimertinib Plus MET Inhibitors in Patients With EGFR-Mutant MET-Amplified NSCLC.
Wang, Kaiwen; Du, Robyn; Roy-Chowdhuri, Sinchita; Li, Ziping T; Hong, Lingzhi; Vokes, Natalie; Elamin, Yasir Y; Hume, Celyne Bueno; Skoulidis, Ferdinandos; Gay, Carl M; Blumenschein, George; Fossella, Frank V; Tsao, Anne; Zhang, Jianjun; Karachaliou, Niki; O'Brate, Aurora; Gann, Claudia-Nanette; Lewis, Jeff; Rinsurongkawong, Waree; Lee, J Jack; Gibbons, Don Lynn; Vaporciyan, Ara A; Heymach, John V; Altan, Mehmet; Le, Xiuning.
Afiliação
  • Wang K; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Du R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Roy-Chowdhuri S; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Li ZT; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hong L; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Vokes N; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Elamin YY; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hume CB; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Skoulidis F; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gay CM; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Blumenschein G; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fossella FV; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tsao A; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhang J; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Karachaliou N; The Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • O'Brate A; The Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Gann CN; The Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Lewis J; Department of Quantitative Research Computing, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rinsurongkawong W; Department of Quantitative Research Computing, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gibbons DL; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Vaporciyan AA; Department of Thoracic & Cardiovasc Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Heymach JV; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Altan M; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Le X; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
JTO Clin Res Rep ; 4(8): 100533, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37649681
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: JTO Clin Res Rep Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: JTO Clin Res Rep Ano de publicação: 2023 Tipo de documento: Article